Introduction
Chagas' disease is endemic in large areas of the southern half of the western hemisphere, and affects more than 10 million people (1) . Cardiac abnormalities including biventricular failure, severe brady-or tachyarryhthmias, and aneurysms ofthe left ventricular apex are the most important clinical consequences ofthis disease (1) . Since in the mammalian host Trypanosoma cruzi can only multiply within cells, the parasite's initial interaction with host cells must be essential in the pathogenesis of Chagas' disease. Nogueira and colleagues (2, 3) have examined in detail the interaction of this parasite with the macrophage. Others have studied the interaction of T cruzi with certain established cell lines, particularly fibroblasts (4) (5) (6) . We recently described a neuraminidase activity associated with the surface of infective forms of T. cruzi that can remove sialic acid from mammalian erythrocytes both in vitro and in vivo (7, 8) . ' However, none of these previous studies have focused on the interaction of T cruzi with the differentiated cardiovascular cells that are the important targets in the pathogenesis ofChagasic heart disease. The surfaces of myocardial and vascular endothelial cells also contain functionally important sialylated macromolecules that are potential substrates for this enzyme. Accordingly, this study tested whether the neuraminidase associated with infective forms of T. cruzi could modify by desialylation the surfaces of intact, functioning mammalian myocardial and vascular endothelial cells in' primary culture. Because of the multiple important biological functions of surface sialoglycoproteins and the many consequences of desialylation, such modification might play a role in the interaction of this parasite with these clinically important host cells.
Methods
Sources and preparations of T. cruzi. T. cruzi trypomastigotes of two different strains (Y and Montalvania) were propagated in cultured bovine aortic smooth muscle cells, prepared as described previously (9) . ' 3-5 d after initial infection, amastigote forms were harvested from the culture supernatants. Trypomastigote forms were harvested from similar cultures infected for 7-10 d, and were purified on a metrizamide gradient (7) .
After harvesting the parasites were washed three times' in phosphatebuffered saline (PBS; NaCl, 150 mM; NaPO4, 10 mM; pH 7 .2) and counted in a hemocytometer.
Preparation and assay ofT. cruzi neuraminidase. A crude preparation of soluble T. cruzi neuraminidase was made by incubating trypomastigotes with Dulbecco's modified Eagle's medium (DME)' or RPMI 1640 medium at 4VC for 48-72 h. Tld neuraminidase activity in this and other materials was measured by the hemagglutination of rabbit erythrocytes using peanut agglutinin as described previously (7, 8) . 1 U of neuraminidase is defined as the amount of enzyme that hydrolyzes 1 4mol ofN-acetyl-neuraminic acid from hiiuman acid alpha,-glycoprotein per minute at 370C (8) .
We detected no difference in the substrate specificities of the neuraminidase produced by these two strains (data not shown). However, preparations from the Montalvania strain generally had higher titers of neuraminidase activity than those from the more widely studied Y strain.
In general, 106 trypomastigotes ofthe Y strain yielded '-7 sU ofactivity, 1 . Abbreviation used in this paper: DME, Dulbecco Preparation ofneonatal rat heart cell cultures. Myocardial cells were prepared by trypsin dissociation ofhearts of 1-2-d-old rat pups, enriched for cardiac myocytes by differential adhesion, and plated at 2 X 105/cm2 (10) . To retard the proliferation ofnonmyogenic cells further, the medium was changed to DME containing fetal calf serum (10%) and cytosine arabinoside (10-s M) the day after initial plating. After 3 d of incubation in this medium, the cultures consisted mostly of contractile cells with the characteristic phase microscopic appearance of cardiac myocytes. Cells were generally used for experiments within I wk of preparation.
Preparation . After a 48-h incubation with tritiated N-acetyl-D-mannosamine under these conditions, followed by four 1-h washing periods in fresh medium without radioactive precursor, <20% of the radioactivity associated with the cell layer was in the form of material soluble in perchloric acid (0.2 M). Thus, this procedure primarily labeled macromolecules. Incubation of cells labeled in this manner with purified neuraminidase from Vibrio cholera (5 MU/ml; Gibco, Grand Island, NY) released 19±3% of the radioactivity associated with the cell layer (n = 5). These results indicate that at least a fifth of the labeled macromolecules were accessible to an exogenous hydrolase.
Although N-acetyl-D-mannosamine is a direct and relatively specific precursor of sialic acid, transport of this acetylated sugar may be less efficient than transport of the less direct precursor D-mannosamine (11, 12) . Therefore, we simultaneously compared labeling characteristics in dual isotope experiments with tritiated N-acetyl-D-mannosamine and '4C-labeled mannosamine. Rat myocardial cells were incubated in the presence of the tritiated precursor (1 ACi/ml) and '4C-D-mannosamine (0.5 ACi/ml) for 65 h. After four 1-h washes with fresh medium, the monolayers were fractionated into material soluble and insoluble in perchloric acid (0.2 M). While cultured myocardial cells took up much more radioactivity from the unacetylated sugar, the proportion of mannosamine incorporated into macromolecules was much less than in the case of N-acetyl-D-mannosamine (data not shown). Although N-acetyl-D-mannosamine did prove to be a more specific label for macromolecules, experiments were often performed using both precursors simultaneously. While we generally present results with N-acetyl-D-mannosamine, similar results were always obtained with the unacetylated mannosamine.
In some experiments, cellular proteins were labeled by incubation with '4C-tyrosine (uniformly labeled 460 mCi/mM, 0.2 MCi/ml). After the cell layers were washed as described above, -94% of the radioactivity was insoluble in perchloric acid (0.2 M).
Chromatographic analysis ofsialic acid. To determine the distribution of radioactivity released from metabolically labeled cardiac cells, the supernatants were analyzed by chromatography (13, 14) . Material released from metabolically labeled cells was Iyophilized, applied to columns (1 by 3 cm) of Dowex 2X-8 (in the formate form) and washed with water (10 column volumes). This effluent contained < 15% of the total radioactivity. The anionic material bound to the column was eluted with formic acid (2 M, 10 column volumes). Total recovery of radioactivity from this ion exchange column was >89%. The acid eluate was evaporated to dryness, dissolved in sulfuric acid (6 N, 0.2 ml), and analyzed by high performance liquid chromatography on an Aminex HPX-87H organic acid column (Bio-Rad Laboratories, Richmond, CA) that was eluted isocratically with sulfuric acid (3 mM) at 0.7 ml/min. Fractions were analyzed for radioactivity by liquid scintillation spectrometry. The column was standardized with D-mannose, N-acetyl-D-mannosamine, N-acety!-neuraminic acid, and N-glycolyl-neuraminic acid.
Galactose with biotinylated peanut agglutinin (20 Ag/ml), washed three times for 5 min with PBS, and then incubated with avidin-biotin-peroxidase complex as described previously ( 17) . Horseradish peroxidase was visualized by incubation with PBS containing 3,3'diaminobenzidine tetrahydrochloride and H202. The slides were then washed in tap water for 5 min, counterstained with methyl green, dehydrated, and coverslips were attached with permount. Positive staining was demonstrated by the dark diaminobenzidine-H202 reaction product.
Results
T. cruzi neuraminidase releases sialic acidfrom metabolically labeled myocardial cells. Soluble neuraminidase shed by intact T. cruzi trypomastigotes released radioactivity originating from both tritiated N-acetyl-D-mannosamine and 14C-mannosamine at an approximately constant rate for I h at 37°C (Fig. 1) . Subsequent experiments therefore generally measured release of radioactivity during the first hour when the rate reflected the apparent initial velocity of the reaction. Spontaneous release of radioactivity was always measured simultaneously in enzymefree blank conditions, and averaged 13±1.3% of the release induced by V. cholera neuraminidase (5 gU/ml, Gibco; mean±SEM of average values from seven independent experiments each performed on 4-6 replicate wells). In preliminary experiments under these conditions, this concentration of the bacterial neuraminidase was maximally effective (data not shown).
In each of seven independent experiments, soluble neuraminidase from T. cruzi (either Y or Montalvania strains) caused net release of radioactivity. The activity of individual preparations of T cruzi neuraminidase depends on such factors as time of storage and strain of origin. Accordingly, the amount ofsialic acid release varied in individual experiments. In five experiments, the release induced by T. cruzi conditioned medium was measured in parallel with that produced by V cholera neuraminidase (5 gU/ml). In these experiments, T. cruzi neuraminidase released from 10 to 113% (mean 67%) of the radioactivity released by this constant amount of V. cholera enzyme.
Characterization of the radioactive products released by T. cruzi neuraminidasefrom metabolically labeled myocardial cells. The release ofradioactivity from metabolically labeled cells might conceivably be due to proteolytic activity elaborated by T. cruzi or that may contaminate the V. cholera neuraminidase. To test this possibility, we measured simultaneously the release of radioactivity from myocardial cells labeled with both tritiated Nacetyl-D-mannosamine (to label sialic acid) and "4C-tyrosine (to label protein). Neuraminidase from either T. cruzi or V. cholera increased release of radioactivity originating from tritiated Nacetyl-D-mannosamine greater than sixfold, but did not release '4C-radioactivity from labeled proteins (Table I ). In contrast, treatment with the proteolytic enzyme trypsin (5 ug/ml) increased the release of radioactivity associated with both the protein and the sugar label to the same extent. This result indicates that while trypsin cleaves glycopeptides containing both amino acids and carbohydrate residues from externally disposed glycoproteins, the neuraminidase activity released by T. cruzi selectively releases carbohydrate moieties.
To define further the chemical identity of the radioactive material(s) released by neuraminidase from myocardial cell surfaces labeled with N-acetyl-D-mannosamine, we analyzed these Figure 2 . High performance liquid chromatography of material released from rat heart cells metabolically labeled with tritiated-N-acetylmannosamine. Neonatal rat myocardial cell cultures were labeled with tritiated N-acetyl-D-mannosamine, washed, and incubated with T. cruzi neuraminidase or V. cholera neuraminidase (5 U/ml for 1 h) as described in the Methods section. Greater than 85% of the radioactivity released into the medium bound to Dowex 2X-8 at neutral pH.
The material eluted from the Dowex columns by formic acid (2 M) was applied to an Aminex HPX-87H high performance liquid chromatography column eluted as described in the Methods section. The recovery of the radioactivity from this column was 89% in the case of T. cruzi neuraminidase. experiments confirm that sialic acid is the major radioactive species released by T. cruzi neuraminidase from myocardial cells metabolically labeled with N-acetyl-D-mannosamine.
Intact living T. cruzi trypomastigotes release sialic acidfrom myocardial cells. The foregoing experiments indicated that neuraminidase shed by T. cruzi can remove sialic acid from the myocardial cell surface. It was also important to determine if the intact parasite could desialylate myocardial cells. Live T. cruzi trypomastigotes released metabolically labeled sialic acid from rat heart cells in three independent experiments with the Y strain. In a representative experiment, net release ofsialic acid with 5 X 108 cells/ml was 1,268±362 dpm/h. Incubation of rat heart cells with trypomastigotes of the myotropic Montalvania strain also induced release of sialic acid in a concentration dependent manner (Fig. 3 ). These results demonstrate that intact, living T. cruzi can release sialic acid from the surface of beating rat myocardial cells.
Noninfective amastigoteforms of T. cruzifail to release sialic acid from myocardial cells. Neuraminidase production by T. cruzi depends on the developmental stage of the organism. The infective trypomastigote form expresses a high titer of activity while noninfective epimastigotes, found in the insect vector and under some conditions in vitro, express much smaller amounts of this activity (7) . Amastigotes, the intracellular replicative form of T. cruzi, neither infect cells nor produce neuraminidase. We isolated amastigotes and trypomastigotes from bovine aortic smooth muscle cells infected simultaneously with the Montalvania strain of T. cruzi. We then exposed metabolically labeled rat myocardial cells to optimum concentrations of either live trypomastigotes or an equal number of amastigotes (108 organisms/ml). The amastigotes did not release sialic acid, while T. cruzi trypomastigotes or purified V. cholera neuraminidase did remove sialic acid from the myocardial cells under identical conditions (Fig. 4) .
Specific myocardial cell surface glycoprotein substrates of T. cruzi neuraminidase. The above experiments demonstrated release of sialic acid from externally disposed glycoconjugates on the myocardial cell surface. To characterize further the substrates for T. cruzi neuraminidase, we used galactose oxidase labeling, with the enzyme galactose oxidase. This newly formed aldehyde group is then reduced by treatment with sodium borotritiide, which introduces two tritium atoms into each desialylated position in the oligosaccharide chain. Extracts of cultures labeled in this manner after neuraminidase treatment were analyzed by electrophoresis (Fig. 5) . Each lane of this gel contained equal amounts of protein stainable by Coomassie Blue (Fig. 5 A) . Cell cultures that had not been treated with neuraminidase showed no tritiated protein bands (Fig. 5 B) . However, cultures treated with neuraminidase from either T. cruzi or V. cholera showed labeled protein bands in a similar pattern (Fig. 5 B, righthand  lanes) . One of these bands had an apparent molecular weight >200,000. This electrophoretic behavior is similar to that ofthe well-known cell surface glycoprotein fibronectin.
Histochemical evidence for desialylation of myocardial cell surface molecules. To verify the results obtained with metabolic labeling and galactose oxidase labeling experiments we used an independent technique. Galactose residues uncovered by desialylation of oligosaccharide chains will bind peanut agglutinin (17) . The appearance of binding sites for this galactose-binding lectin was visualized by an avidin-biotin immunoperoxidase linked technique. Cultures of rat myocardial cells not treated with neuraminidase showed no binding of peanut agglutinin. However, after incubation with neuraminidase from either T. cruzi or V. cholera, myocardial cell cultures showed abundant binding of this lectin (Fig. 6) .
T cruzi neuraminidase also releases sialic acidfrom adult human vascular endothelial cells. Blood-borne trypomastigotes in the mammalian host must cross the endothelial barrier to invade peripheral tissues such as myocardium. In addition, desialylation of endothelium can increase platelet adhesion to arteries (18). Therefore, we determined whether T. cruzi neuraminidase could also remove sialic acid from vascular endothelial cells. Neuraminidase from T. cruzi did release metabolically labeled sialic acid from adult human saphenous vein endothelial cells (Fig. 7) , as well as from bovine aortic endothelial cells (data not shown). This result was confirmed by histochemical studies that showed binding of peanut lectin to neuraminidase-treated but not to control cultures of adult human endothelial cells (Fig. 8 ).
Discussion
Death due to Chagas' disease is usually caused by chronic cardiac involvement (1) . The etiologic agent of this disease, T. cruzi, is an obligate intracellular parasite. During the acute phase of Chagas' disease the parasites enter and multiply within myocardial cells, and their progeny must exit from these cells in order to propagate the infection. Before encountering the myocardial and other potential target cells, the blood-borne trypomastigote must traverse the vascular endothelium. For the parasite to enter or exit myocardial or endothelial cells, it must contact two structures rich in functionally important sialylated glycoproteins: the basement membrane or glycocalyx, and the plasmalemma itself (19) (20) (21) (22) .
Sialoglycoconjugates of the cell surface play many important roles in physiology and pathology (23) . In some preparations of cardiac tissue, negatively charged sialic acid residues appear to modulate the access of calcium ions to the sarcolemma (19, 22, (24) (25) (26) . Desialylation of mammalian cells can also activate the alternative pathway of complement (27). Sialyl residues on the lumenal surface of vascular endothelium can also influence the interactions of blood cells with the vessel wall in important ways (28). For example, treatment with neuraminidase promotes the adhesiveness of platelets (18) and granulocytes (29) to endothelium. Desialylation of the endothelial surface could contribute to the platelet aggregation and thrombosis within coronary arteries that accompany cardiac fibrosis in mice infected experimentally with T. cruzi (30, 31) . In addition, sialyl residues may account for the selective adhesion ofcirculating lymphocytes to specialized venular endothelial cells in peripheral lymph nodes (32) .
We previously demonstrated that during infection of mice with T. cruzi, desialylation of erythrocytes occurs in vivo in relation to the degree ofparasitemia (7) . Desialylated erythrocytes are liable to sequestration perhaps via the asialoglycoprotein pathway, and are subject to lysis by the alternative pathway of complement (27, 33). Therefore, this action of T. cruzi neuraminidase probably explains the anemia associated with acute T. cruzi parasitemia (34) . However, alteration by T. cruzi of the surfaces of myocardial and endothelial cells could be more relevant to development of the later and often lethal chronic phase of Chagas' disease.
For this reason, it was of interest to determine whether the activity of this enzyme of parasite origin was limited to erythrocytes, or if it could also hydrolyze sialylated glycoconjugates present on the surfaces of these pathologically important target cells. By a variety of independent criteria, we found that T. cruzi can indeed desialylate the surfaces ofboth ofthese cardiovascular cell types in vitro. Soluble neuraminidase shed by infective T. cruzi trypomastigotes removed sialic acid from these cells as shown by release of free sialic acid, lectin binding, and cytochemistry.
More importantly, living T. cruzi trypomastigotes also released sialic acid from intact beating myocardial cells. (37) (38) (39) .
